Pancreatic neuroendocrine neoplasms: Updates on genomic changes in inherited tumour syndromes and sporadic tumours based on WHO classification
- 4 March 2022
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 172, 103648
Abstract
No abstract availableKeywords
This publication has 174 references indexed in Scilit:
- MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease ControlsClinical Cancer Research, 2013
- Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine TumorsAmerican Journal of Surgical Pathology, 2012
- Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre databaseClinical Endocrinology, 2011
- von Hippel–Lindau disease: A clinical and scientific reviewEuropean Journal of Human Genetics, 2011
- DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine TumorsScience, 2011
- The Tumor Suppressor Protein Menin Inhibits AKT Activation by Regulating Its Cellular LocalizationCancer Research, 2011
- Causes and consequences of microRNA dysregulation in cancerNature Reviews Genetics, 2009
- Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor InitiationMolecular Cell, 2009
- The many facets of Notch ligandsOncogene, 2008
- A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomasBritish Journal of Cancer, 2006